Wolverine Trading
CORV

Wolverine Trading’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Wolverine Trading’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-11,247
Closed -$40.8K – 5257
2017
Q1 		$34K Sell
11,247
-11,705
-51% -$34.5K ﹤0.01% 4053
2016
Q4 		$63K Sell
22,952
-197
-0.9% -$563 ﹤0.01% 4175
2016
Q3 		$72K Buy
23,149
+11,118
+92% +$40.5K ﹤0.01% 4313
2016
Q2 		$61K Buy
+12,031
New +$57.8K ﹤0.01% 3784

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
AIS
AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return

Wolverine Trading's CORV Position: Q2 2017 in Review

Wolverine Trading sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2017, closing a stake of 11,247 shares — an estimated $40.8K sold.

Wolverine Trading first reported a position in CORV in Q2 2016 and held it in 4 quarters. The position peaked at $72K in Q3 2016. 27 funds tracked by Wall St. Rank hold CORV as of Q2 2017.

  • Wolverine Trading reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2017 after selling out during the quarter.
  • Wolverine Trading sold 11,247 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2017, an estimated $40.8K.
  • Wolverine Trading first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2016 and held it in 4 quarters.
  • Wolverine Trading's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $72K in Q3 2016.
  • 27 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2017.

Based on Wolverine Trading's 13F filing for Q2 2017, filed 14 Aug 2017.